350 related articles for article (PubMed ID: 17313509)
1. Assessment of a national monitoring and evaluation system for rapid expansion of antiretroviral treatment in Malawi.
Lowrance D; Filler S; Makombe S; Harries A; Aberle-Grasse J; Hochgesang M; Libamba E
Trop Med Int Health; 2007 Mar; 12(3):377-81. PubMed ID: 17313509
[TBL] [Abstract][Full Text] [Related]
2. Surveillance of transmitted HIV drug resistance with the World Health Organization threshold survey method in Lilongwe, Malawi.
Kamoto K; Aberle-Grasse J;
Antivir Ther; 2008; 13 Suppl 2():83-7. PubMed ID: 18575195
[TBL] [Abstract][Full Text] [Related]
3. World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites.
Jordan MR; Bennett DE; Bertagnolio S; Gilks CF; Sutherland D
Antivir Ther; 2008; 13 Suppl 2():15-23. PubMed ID: 18575188
[TBL] [Abstract][Full Text] [Related]
4. Early warning indicators for HIV drug resistance in Malawi.
Hedt BL; Wadonda-Kabondo N; Makombe S; Harries AD; Schouten EJ; Limbambala E; Hochgesang M; Aberle-Grosse J; Kamoto K
Antivir Ther; 2008; 13 Suppl 2():69-75. PubMed ID: 18575193
[TBL] [Abstract][Full Text] [Related]
5. The World Health Organization's global strategy for prevention and assessment of HIV drug resistance.
Bennett DE; Bertagnolio S; Sutherland D; Gilks CF
Antivir Ther; 2008; 13 Suppl 2():1-13. PubMed ID: 18578063
[TBL] [Abstract][Full Text] [Related]
6. [The introduction of antiretroviral therapy in Malawi].
Zijlstra EE; van Oosterhout JJ
Ned Tijdschr Geneeskd; 2006 Dec; 150(50):2774-8. PubMed ID: 17225792
[TBL] [Abstract][Full Text] [Related]
7. A national survey of prisoners on antiretroviral therapy in Malawi: access to treatment and outcomes on therapy.
Makombe SD; Jahn A; Tweya H; Thambo L; Yu JK; Hedt B; Weigel R; Nkhata A; Schouten EJ; Kamoto K; Harries AD
World Hosp Health Serv; 2008; 44(1):26-9. PubMed ID: 18549031
[TBL] [Abstract][Full Text] [Related]
8. Monitoring the response to antiretroviral therapy in resource-poor settings: the Malawi model.
Harries AD; Gomani P; Teck R; de Teck OA; Bakali E; Zachariah R; Libamba E; Mwansambo A; Salaniponi F; Mpazanje R
Trans R Soc Trop Med Hyg; 2004 Dec; 98(12):695-701. PubMed ID: 15485699
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of tuberculosis patients who start antiretroviral therapy under routine programme conditions in Malawi.
Makombe SD; Harries AD; Yu JK; Hochgesang M; Mhango E; Weigel R; Pasulani O; Fitzgerald M; Schouten EJ; Libamba E
Int J Tuberc Lung Dis; 2007 Apr; 11(4):412-6. PubMed ID: 17394687
[TBL] [Abstract][Full Text] [Related]
10. Current progress of China's free ART program.
Zhang FJ; Pan J; Yu L; Wen Y; Zhao Y
Cell Res; 2005; 15(11-12):877-82. PubMed ID: 16354563
[TBL] [Abstract][Full Text] [Related]
11. A national survey of prisoners on antiretroviral therapy in Malawi: access to treatment and outcomes on therapy.
Makombe SD; Jahn A; Tweya H; Thambo L; Yu JK; Hedt B; Weigel R; Nkhata A; Schouten EJ; Kamoto K; Harries AD
J Infect Dev Ctries; 2007 Dec; 1(3):303-7. PubMed ID: 19734609
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of an observational database to assess antiretroviral treatment trends in India.
Cecelia AJ; Christybai P; Anand S; Jayakumar K; Gurunathan T; Vidya P; Solomon S; Kumarasamy N
Natl Med J India; 2006; 19(1):14-7. PubMed ID: 16570679
[TBL] [Abstract][Full Text] [Related]
13. Can the initial success of the Malawi ART scale-up programme be sustained? The example of Queen Elizabeth Central Hospital, Blantyre.
van Oosterhout JJ; Kumwenda JK; Hartung T; Mhango B; Zijlstra EE
AIDS Care; 2007 Nov; 19(10):1241-6. PubMed ID: 17886172
[TBL] [Abstract][Full Text] [Related]
14. Public-sector ART in the Free State Province, South Africa: community support as an important determinant of outcome.
Wouters E; Van Damme W; Van Loon F; van Rensburg D; Meulemans H
Soc Sci Med; 2009 Oct; 69(8):1177-85. PubMed ID: 19692165
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of patients with Kaposi's sarcoma who start antiretroviral therapy under routine programme conditions in Malawi.
Makombe SD; Harries AD; Yu JK; Hochgesang M; Mhango E; Weigel R; Pasulani O; Fitzgerald M; Schouten EJ; Libamba E
Trop Doct; 2008 Jan; 38(1):5-7. PubMed ID: 18302849
[TBL] [Abstract][Full Text] [Related]
16. Using a file audit to evaluate retention in care and patient outcomes in a programme to decentralise antiretroviral treatment to primary health care facilities in a high prevalence setting in KwaZulu-Natal, South Africa.
Searle C; Ramkissoon A; Govender T
Stud Health Technol Inform; 2010; 160(Pt 1):476-80. PubMed ID: 20841732
[TBL] [Abstract][Full Text] [Related]
17. The Chinese free antiretroviral treatment program: challenges and responses.
Zhang F; Haberer JE; Wang Y; Zhao Y; Ma Y; Zhao D; Yu L; Goosby EP
AIDS; 2007 Dec; 21 Suppl 8():S143-8. PubMed ID: 18172383
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a case management program for HIV clients in Rwanda.
Thurman TR; Haas LJ; Dushimimana A; Lavin B; Mock N
AIDS Care; 2010 Jun; 22(6):759-65. PubMed ID: 20461574
[TBL] [Abstract][Full Text] [Related]
19. Directions for national data policy for antiretroviral therapy in resource-poor settings: a focus on durable viral suppression.
Pappas G; Andriote JM; Mwalali P
AIDS Public Policy J; 2005; 20(3-4):66-73. PubMed ID: 17624030
[TBL] [Abstract][Full Text] [Related]
20. Scaling up antiretroviral therapy in Africa: learning from tuberculosis control programmes--the case of Malawi.
Libamba E; Makombe S; Harries AD; Chimzizi R; Salaniponi FM; Schouten EJ; Mpazanje R
Int J Tuberc Lung Dis; 2005 Oct; 9(10):1062-71. PubMed ID: 16229216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
